Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Telephone: +44 2072104850
E-mail: john.cook@dhsc.gov.uk
NUTS: UK
Internet address(es)
Main address: https://dh.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contracts for the Supply of Azithromycin and Dexamethasone Products
Reference number: CM/EMP/20/1546/1
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
A requirement for the supply of azithromycin and dexamethasone products.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
305 793.80
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Movianto, Haydock.
II.2.4) Description of the procurement
A requirement to secure azithromycin and dexamethasone products for trials for treatments for Covid-19 — urgent delivery required for available stocks.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the Directive
Explanation
Given the spread of Covid-19 pandemic in the UK (and Worldwide), research remains ongoing and constantly evolving to find effective ways of curtailing the virus. Azithromycin and Dexamethasone are medicinal products that are being investigated for the treatment of Covid-19 and need to be trialled before the treatments can be rolled out more widely for Covid-19 patients in sufficient quantities. For the safety and assurance of all concerned, DHSC observes a detailed governance process for clinical trials which was followed. On completion of this process, DHSC had to move very quickly to secure the medicinal products in order to complete the trials as soon as possible. This is in order that where the trials are successful it could purchase substantive quantities of the medicinal products to be used for the treatment of Covid-19.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/04/2020
V.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Rosemont Pharmaceuticals Ltd
Leeds
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 105 750.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/04/2020
V.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Aspen Pharma Ireland Ltd
Dublin 2
IE
NUTS: IE
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 63 019.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/04/2020
V.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Hameln Pharmaceuticals Ltd
Gloucester
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 11 682.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/04/2020
V.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Milpharm Ltd
London
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 44 352.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/04/2020
V.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Teva UK Ltd
Castleford
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 80 990.80
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The contracts are for the benefit of the Authority and NHS Bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
These contracts were awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of azithromycin and dexamethasone medicinal products for trials for the treatment of Covid-19. The procurement exercise was commenced by the contracting authority on 3 April 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 7 April 2020.
While the procurement was not specifically divided into lots, the contracting authority awarded a number of contract simultaneously in order to meet its requirement.
VI.4) Procedures for review
VI.4.1) Review body
The High Court
The Strand
London
UK
VI.5) Date of dispatch of this notice
11/06/2020